A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose

Study summary

Data collection and assessment on patients with left-sided breast cancer or undergoing lung stereotactic body radiation therapy (SBRT) utilizing continuous positive airway pressure (CPAP) devices.

Ask AI to explain this study

Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedContinuous Positive Airway Pressure and Deep inspiratory breath hold

Plus 1 other study approaches.

Who it may be forLung Cancer · Left Sided Breast Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Feb 2, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Case Comprehensive Cancer Center

Study sponsor

Study overview

What this study is about

Purpose: Supportive Care
Study type: Interventional
Phase: Not applicable
Sponsor: Case Comprehensive Cancer Center
Interventions being studied: Device: Continuous Positive Airway Pressure; Other: Deep inspiratory breath hold; Other: Free Breath

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Radiation therapy→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Patients with left-sided breast cancers
Patients must be undergoing left breast/chest wall radiation with or without regional nodal irradiation
Patients undergoing lung SBRT
Primary lung cancers
Metastatic lung tumors

Reasons someone may not be able to joinExclusion criteria

Patients with right side breast cancer
Patients who are unable to tolerate the CPAP device

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer CenterCleveland, Ohio

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 2, 2026. Always confirm current availability with the study team.

View original record ↗